Find investors
← Back to all investors
EG
ResearchedAngel Investors

Edouard Grutering

General Partner

Angel InvestorsSeed Round
Pitch Edouard

Get their honest, personalized take on your startup.

Sign in to pitch Edouard

At a glance

Full Name
Edouard Grutering
Title
General Partner
Firm
Nausicaa Ventures
Firm Type
Early-stage venture capital fund organisation
Investment Stage
Early stage / early growth; 3rd or 4th financing rounds, described by the firm as Series C or D
Check Size
Fund targets rounds of EUR 1 million to EUR 4 million
Target Company Profile
Early-stage and early-growth companies raising EUR 1 million to EUR 4 million, preferably with angel investors or family offices already present
Sector Focus
ICT, medtech, cleantech, other high-tech and related industries; traditional sectors such as manufacturing are also considered
Geographic Focus
Belgium and nearby markets, typically within 300 km of Brussels
Location
Belgium

Background

Edouard Grutering is a General Partner of Nausicaa Ventures, acting through AlphaQuest sprl. Nausicaa Ventures describes itself as a multi-industry early-stage venture capital fund created in 2009 by bringing together 35 private investors and selected institutional investors, including the European Investment Fund and ING Bank.

Before joining Nausicaa Ventures, Grutering worked as an analyst with an energy consultancy firm. He holds a Master's degree in International Business and Management from ICHEC in Belgium, and a Master of Arts degree in International Finance and International Energy Policy from the Johns Hopkins School of Advanced International Studies in Baltimore, Maryland.

Investment Thesis & Focus

  • Nausicaa Ventures targets investments where “significant value creation” is potentially in sight.
  • The fund focuses on early-stage and early-growth companies completing their 3rd or 4th financing round, which it describes as Series C or D, with a view to raising EUR 1 million to EUR 4 million.
  • Sector focus includes ICT, medtech, cleantech, other high-tech and related industries; the firm also considers more traditional sectors such as manufacturing.
  • The fund generally avoids long-horizon biotechnology projects.
  • Geographic focus is projects in and around Belgium, typically within 300 km of Brussels.
  • Nausicaa has a particular interest in companies where angel investors or family offices are already present.
  • The firm expects to be hands-on: it says it can “get its hands dirty” in helping portfolio companies with growth, financing rounds, profitability, and exit.
  • Nausicaa states that it would generally not invest where the collective contribution of its members would not be significant.

Notable Investments

  • NGDATA - Customer experience management and big-data platform for real-time customer profiles and personalized targeting.
  • Bio-Sourcing - Developer of biological therapeutics for veterinary use in partnership with animal-health companies.
  • Bone Therapeutics - ULB spin-off developing autologous and allogenic cell-therapy products for bone repair and regeneration.
  • Ovizio Imaging Systems - ULB spin-off developing and marketing 3-D imaging systems and sensors based on Digital Holographic Microscopy.

Unlock the full research

Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.

One-time. Stays unlocked for you.